{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:40:44Z","timestamp":1781628044545,"version":"3.54.5"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0148595","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T19:06:18Z","timestamp":1455303978000},"page":"e0148595","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy"],"prefix":"10.1371","volume":"11","author":[{"given":"Yunhai","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0301-4738.94048","article-title":"Thyroid associated orbitopathy","volume":"60","author":"R Maheshwari","year":"2012","journal-title":"Indian Journal of Ophthalmology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","article-title":"Pathogenesis of graves\u2019 ophthalmopathy","volume":"329","author":"RS Bahn","year":"1993","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0303-7207(96)03986-X","article-title":"Eyeing up graves\u2019 ophthalmopathy","volume":"126","author":"AP Weetman","year":"1997","journal-title":"Mol Cell Endocrinol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0035-1554721","article-title":"Medical Treatment of Graves' Orbitopathy","volume":"47","author":"M Salvi","year":"2015","journal-title":"Hormone and Metabolic Research"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/01676839609150233","article-title":"Cell-mediated immunity in thyroid-associated ophthalmopathy","volume":"15","author":"K Arnold","year":"1996","journal-title":"Orbit"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/08916939708996275","article-title":"High circulating IL-6 level in graves\u2019 ophthalmopathy","volume":"25","author":"I Moln\u00e1r","year":"1997","journal-title":"Autoimmun"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1055\/s-0033-1343451","article-title":"Current insights into animal models of Graves' disease and orbitopathy","volume":"45","author":"B Wiesweg","year":"2013","journal-title":"Hormone and Metabolic Research"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/s-0035-1555956","article-title":"Modeling Graves' Orbitopathy in Experimental Graves' Disease","volume":"47","author":"JP Banga","year":"2015","journal-title":"Hormone and Metabolic Research"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0029-1220935","article-title":"Current insights into the pathogenesis of Graves' orbitopathy","volume":"41","author":"AK Eckstein","year":"2009","journal-title":"Hormone and Metabolic Research"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2174\/1381612821666150316121945","article-title":"Preclinical models of Graves' disease and associated secondary complications","volume":"21","author":"S Moshkelgosha","year":"2015","journal-title":"Curr Pharm Des"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for graves' hyperthyroidism. The Thyroid Study Group","volume":"326","author":"L Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"ref12","first-page":"168","article-title":"Management of graves\u2019 ophthalmopathy: reality and perspectives","volume":"21","author":"L Bartalena","year":"2000","journal-title":"Endocr Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for graves\u2019 hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"F Tr\u00e4isk","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/bjo.2003.035915","article-title":"Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression","volume":"88","author":"AK Eckstein","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"AK Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of graves' ophthalmopathy","volume":"338","author":"L Bartalena","year":"1998","journal-title":"N Engl J Med"},{"key":"ref17","first-page":"00165","article-title":"Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma-A systematic review","volume":"10","author":"SC Clement","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"ref18","first-page":"241","article-title":"The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves' Ophthalmopathy","volume":"34","author":"A Czarnywojtek","year":"2013","journal-title":"Neuro Endocrinol Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","article-title":"Diagnostic criteria for graves\u2019 ophthalmopathy","volume":"119","author":"GB Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0161-6420(97)30207-3","article-title":"The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy","volume":"104","author":"KP Cockerham","year":"1997","journal-title":"Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/IJG.0b013e31822e8c4f","article-title":"Comparison of optic disc topography in the cases with graves\u2019 disease and healthy controls","volume":"21","author":"E Sen","year":"2012","journal-title":"J Glaucoma"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/jama.1990.03440110095035","article-title":"American Thyroid Association guidelines for use of laboratory tests in thyroid disorders","volume":"263","author":"MI Surks","year":"1990","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0889-8529(05)70281-4","article-title":"Biochemical testing of thyroid function","volume":"26","author":"GG Klee","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/eye.2013.120","article-title":"Relevance of TSH-receptor antibody levels in predicting disease course in Graves","volume":"27","author":"SY Jang","year":"2013","journal-title":"Eye (Lond)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/thy.2000.10.809","article-title":"Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease","volume":"10","author":"JY Noh","year":"2000","journal-title":"Thyroid"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/eye.1994.159","article-title":"Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy","volume":"8","author":"MD Tsaloumas","year":"1994","journal-title":"Eye (Lond)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/edrv-9-1-106","article-title":"Autoantibodies to the thyrotropin receptor","volume":"9","author":"B Rees Smith","year":"1988","journal-title":"Endocr Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","article-title":"Association of thyrotrophin receptor antibodies with the clinical features of graves' ophthalmopathy","volume":"52","author":"MN Gerding","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.4049\/jimmunol.160.3.1458","article-title":"Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor","volume":"160","author":"S Costagliola","year":"1998","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archopht.1966.03850010246017","article-title":"Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy","volume":"76","author":"AJ Kroll","year":"1966","journal-title":"Arch Ophthalmol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.1.02280","article-title":"Expression of cyclooxygenase-2 in orbital fibroadipose connective tissues of graves\u2019 ophthalmopathy patients","volume":"155","author":"EB Konuk","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/thy.2007.0028","article-title":"COX-2 and SCD, markers of inflammation and adipogenesis, are related to diseaseactivity in graves\u2019 ophthalmopathy","volume":"17","author":"T Vondrichova","year":"2007","journal-title":"Thyroid"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2362.1992.tb01501.x","article-title":"Graves\u2019 immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured graves\u2019 orbital fibroblasts","volume":"22","author":"AE Heufelder","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2362.1993.tb00712.x","article-title":"Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in graves\u2019 ophthalmopathy","volume":"23","author":"AE Heufelder","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00417-012-2092-7","article-title":"Increased serum interleukin-17 in graves\u2019 ophthalmopathy","volume":"250","author":"SE Kim","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0148595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T21:19:21Z","timestamp":1692220761000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0148595"}},"subtitle":[],"editor":[{"given":"Firas H","family":"Kobeissy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0148595","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}